Laszlo Gyenis

London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Novel Pannexin 1 isoform is increased in cancer.

Novel Pannexin 1 isoform is increased in cancer.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells.

Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells.

Journal: Cancer cell international

Published: June 24, 2024

Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.

Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.

Journal: Cell death & disease

Published: May 04, 2023

Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target.

Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target.

Journal: Biochimica et biophysica acta. General subjects

Published: April 04, 2023

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2.

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2.

Journal: Current research in chemical biology

Published: January 01, 2023

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.

Journal: Nature chemical biology

Published: June 16, 2022

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.

Journal: Frontiers in molecular biosciences

Published: March 31, 2022

Pannexin 2 is expressed in murine skin and promotes UVB-induced apoptosis of keratinocytes.

Pannexin 2 is expressed in murine skin and promotes UVB-induced apoptosis of keratinocytes.

Journal: Molecular biology of the cell

Published: January 05, 2022

Pannexin 1 mutation found in melanoma tumor reduces phosphorylation, glycosylation, and trafficking of the channel-forming protein.

Pannexin 1 mutation found in melanoma tumor reduces phosphorylation, glycosylation, and trafficking of the channel-forming protein.

Journal: Molecular biology of the cell

Published: January 06, 2021

Development of a potent and selective chemical probe for the pleiotropic kinase CK2.

Development of a potent and selective chemical probe for the pleiotropic kinase CK2.

Journal: Cell chemical biology

Published: November 05, 2020

CSNK2 in cancer: pathophysiology and translational applications.

CSNK2 in cancer: pathophysiology and translational applications.

Journal: British journal of cancer

Published: July 11, 2020

Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles.

Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles.

Journal: Journal of biomaterials applications

Published: February 10, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026